Company
Headquarters: Lowell, MA, United States
Employees: 8
$6.8 Million
USD as of July 1, 2022
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Viatar CTC Solutions Inc., a biotechnology company, focuses on developing and marketing cancer molecular diagnostics and cancer therapy products in the United States. Its products include Viatar collection system for molecular analysis that collects and purifies circulating tumor cells (CTCs) for DNA sequencing and other genetic analysis technologies used primarily for research; and Viatar therapeutic oncopheresis system to remove CTCs from a patient's blood as a new cancer therapy for metastatic disease. The company was formerly known as Vizio Medical Devices LLC and changed its name to Viatar CTC Solutions Inc. in February 2014. Viatar CTC Solutions Inc. was founded in 2007 and is headquartered in Lowell, Massachusetts.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Viatar CTC Solutions, Inc. has the following listings and related stock indices.
Stock: OTC: VRTT wb_incandescent